Home › Compare › GYSN vs PLD

GYSN vs PLD: Dividend Comparison 2026

GYSN yields 2000000.00% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GYSN wins by $4.879226400974806e+39M in total portfolio value
10 years
GYSN
GYSN
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full GYSN calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — GYSN vs PLD

📍 GYSN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGYSNPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GYSN + PLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
GYSN pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GYSN
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, GYSN beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GYSN + PLD for your $10,000?

GYSN: 50%PLD: 50%
100% PLD50/50100% GYSN
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

GYSN
No analyst data
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GYSN buys
0
PLD buys
0
No recent congressional trades found for GYSN or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGYSNPLD
Forward yield2000000.00% ✓3.10%
Annual dividend / share$2.00$4.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4% ✓
Portfolio after 10y$4.879226400974806e+39M$5.91M ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$4,750,725.19
Total dividends collected$4.879195005460081e+39M$5.78M ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: GYSN vs PLD ($10,000, DRIP)

YearGYSN PortfolioGYSN Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,241$540.96+$200.00M → GYSN
2$3,738,731,768,458$3,738,517,757,009.35$13,019$991.13+$3738731.76M → GYSN
3$65,315,062,866,930,490$65,311,062,423,938,240.00$15,801$1,870.97+$65315062866.91M → GYSN
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$20,609$3,701.21+$1066400830062625.00M → GYSN
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$29,919$7,867.97+$16272182796453826560.00M → GYSN
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$50,631$18,617.74+$2.3205424011366188e+23M → GYSN
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$105,528$51,352.20+$3.0927990661046884e+27M → GYSN
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$287,364$174,449.42+$3.8524105697352695e+31M → GYSN
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$1,081,760$774,280.77+$4.484688260147987e+35M → GYSN
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$5,908,209$4,750,725.19+$4.879226400974806e+39M → GYSN

GYSN vs PLD: Complete Analysis 2026

GYSN — Stock

Greyson International, Inc. engages in the research, development, manufacture, distribution, and marketing of beauty and pharmaceutical products. It offers Trilexon, a skin care delivery system. The company also provides anti-aging skin care products, such as foaming cleansers, pore diminishing toners, moisturizers, night creams, and eye creams under the Trilexon brand name. It offers its products online. Greyson International, Inc. was founded in 1996 and is based in Coconut Creek, Florida.

Full GYSN Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this GYSN vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GYSN vs SCHDGYSN vs JEPIGYSN vs OGYSN vs KOGYSN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.